Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah C Gilbert

Showing results (101-110 of 215) with videos related to

Pageof 22
Sort By:
NPJ Vaccines|October 13, 2024
Aerosol immunization with influenza matrix, nucleoprotein, or both prevents lung disease in pigEleni Vatzia, Basudev Paudyal, Barbara Dema, et al.
Plos One|July 23, 2013
Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in miceFrances E Pearson, Celia L McNeilly, Michael L Crichton, et al.
NPJ Vaccines|October 25, 2019
Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goatsAnna Stedman, Daniel Wright, Paul J Wichgers Schreur, et al.
Plos One|December 19, 2014
A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CSEoghan de Barra, Susanne H Hodgson, Katie J Ewer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomesMichael Walther, John Woodruff, Fanny Edele, et al.
Ebiomedicine|July 19, 2016
What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus ProteinsHillary A Vanderven, Fernanda Ana-Sosa-Batiz, Sinthujan Jegaskanda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1Tamara K Berthoud, Matthew Hamill, Patrick J Lillie, et al.
Vaccine|June 6, 2017
ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in miceNaif Khalaf Alharbi, Eriko Padron-Regalado, Craig P Thompson, et al.
Ebiomedicine|March 18, 2023
Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge modelJack E Saunders, Ciaran Gilbride, Stuart Dowall, et al.
Science Translational Medicine|April 8, 2010
Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glassRobert Alcock, Matthew G Cottingham, Christine S Rollier, et al.
Pageof 22

Showing results (101-110 of 215) with videos related to

Sort By:
Pageof 22
NPJ Vaccines|October 13, 2024
Aerosol immunization with influenza matrix, nucleoprotein, or both prevents lung disease in pigEleni Vatzia, Basudev Paudyal, Barbara Dema, et al.
Plos One|July 23, 2013
Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in miceFrances E Pearson, Celia L McNeilly, Michael L Crichton, et al.
NPJ Vaccines|October 25, 2019
Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goatsAnna Stedman, Daniel Wright, Paul J Wichgers Schreur, et al.
Plos One|December 19, 2014
A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CSEoghan de Barra, Susanne H Hodgson, Katie J Ewer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomesMichael Walther, John Woodruff, Fanny Edele, et al.
Ebiomedicine|July 19, 2016
What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus ProteinsHillary A Vanderven, Fernanda Ana-Sosa-Batiz, Sinthujan Jegaskanda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1Tamara K Berthoud, Matthew Hamill, Patrick J Lillie, et al.
Vaccine|June 6, 2017
ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in miceNaif Khalaf Alharbi, Eriko Padron-Regalado, Craig P Thompson, et al.
Ebiomedicine|March 18, 2023
Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge modelJack E Saunders, Ciaran Gilbride, Stuart Dowall, et al.
Science Translational Medicine|April 8, 2010
Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glassRobert Alcock, Matthew G Cottingham, Christine S Rollier, et al.
Pageof 22